Navigation Links
Oral Allergy Immunotherapy Helps Control Asthma
Date:3/4/2008

Drops or tablets avoid the pain and side effects of shots, review finds

TUESDAY, March 4 (HealthDay News) -- Oral allergy immunotherapy -- in the form of drops or tablets -- is effective at reducing asthma symptoms and the need for asthma medications in children who have what's known as allergic asthma, a new study finds.

The findings bolster hopes that these oral medications might someday replace injections, never a hit with kids.

"[Oral] immunotherapy is effective and safe, easy to administer, well-accepted by patients," said the study's senior author, Dr. Giorgio Walter Canonica, professor of allergy and respiratory disease at the Medical University of Genoa, Italy.

Commonly known as allergy shots in the United States, allergy immunotherapy works in a manner similar to vaccines -- essentially re-educating the body's immune system so that it doesn't overreact to harmless substances such as pollen or dust mites. While this therapy can be effective, it's currently only available via injections in the United States, and usually involves at least one to two shots a week for three to six months, making it a less-than-popular alternative with children.

Oral immunotherapy is available in Europe, but has yet to gain Food and Drug Administration approval in the United States.

The new study reviewed nine studies that looked at the use of so-called sublingual (oral) immunotherapy in children with asthma. A total of 441 kids between the ages of 3 and 18 who had been diagnosed with allergic asthma were included in the studies. Allergic asthma means that asthma symptoms can be triggered by exposure to an allergen, such as dust mites, pollen or mold.

Two hundred and thirty-two children received oral immunotherapy and the remaining 209 got a placebo.

The dosing schedule varied depending on the study and whether drops or tablets were used. Canonica said that during the maintenance phase of immunotherapy, drops or tablets were given three times a week. The average duration of the studies was 12 months. The most common allergen treated was dust mites. Grass mix and pollen were also included in one study each.

The researchers found that those taking sublingual immunotherapy (SLIT) had significantly fewer symptoms and needed to take less asthma medication. Not enough of the studies included measurements of lung function for the new study to assess whether SLIT affects lung function significantly.

"SLIT is highly effective in treating pediatric asthma patients, reducing both symptoms and medication use," said Canonica, who's also president of the World Allergy Organization.

Additionally, SLIT appeared to be better tolerated than allergy shots. The chances of a severe reaction are less with oral immunotherapy than with the injected type, according to Dr. Andrew MacGinnitie, an allergist/immunologist at Children's Hospital of Pittsburgh.

"There have been some rare cases of severe reactions with SLIT, but they're much less common," MacGinnitie said. Another big benefit, he added, is that "shots have to be given in the doctor's office and drops are designed to taken at home."

The results of the new study are published in the March issue of the journal Chest.

Other studies have directly compared SLIT to allergy shots and they're both equally effective, according to Canonica. And MacGinnitie said that, "immunotherapy is really the only treatment that gets to the cause of the allergic response."

"This is a potentially new and exciting treatment for kids with asthma," he concluded.

More information

To learn more about allergy immunotherapy, visit the American Academy of Allergy, Asthma and Immunology.



SOURCES: Giorgio Walter Canonica, M.D., professor, allergy and respiratory disease, Medical University of Genoa, Italy, and president, World Allergy Organization; Andrew MacGinnitie, M.D., allergist/immunologist, Children's Hospital of Pittsburgh; March 2008 Chest


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Allergy Disorders Linked With Irritable Bowel Syndrome
2. NHS Choices Launches New Food Allergy Symptom Checker
3. Allergy Shots Are Effective Treatment for Symptoms
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
5. A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms
6. Protein a possible key to allergy and asthma control
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
8. Parents Smoking Boosts Childs Allergy Risk
9. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
10. Allergy Foundation Thinks Globally, Gifts Locally
11. Tis the Season For Allergy, Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oral Allergy Immunotherapy Helps Control Asthma
(Date:8/23/2017)... ... August 23, 2017 , ... This week the The Voss ... Texas. Founded by Bill Voss, the firm grew quickly and has built a reputation ... of helping clients get the money they deserve from their insurance companies. , ...
(Date:8/23/2017)... ... August 23, 2017 , ... Based on ... safety and efficacy of HBOT in treating and helping to heal addictions and ... research showing the similarities of the wounds to the brain from traumatic brain ...
(Date:8/23/2017)... ... 23, 2017 , ... PreCheck, Inc., a background screening and ... with a three-year sales growth of 49 percent . The Inc. 5000 is ... comprehensive look at America’s independent entrepreneurs. This represents PreCheck’s fifth consecutive entry on ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, the ... to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. ... 139 percent, marking the twelfth year that the company has been included on ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... American Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical ... pain or injury. According to the report, a wider scope of physical therapy ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2017. The cash dividend ... October 27, 2017 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
(Date:8/4/2017)... Md. , Aug. 4, 2017 The ... or shortly after a physician/patient consult has long been ... and was a notable focus of the largest meeting ... is according to healthcare market research firm Kalorama Information. ... care testing (POCT) offerings or related supplies and software ...
(Date:8/2/2017)... Tenn. and BENTON, Ky. , Aug. 2, 2017   ... member to its environmental services (ES) team to proactively reduce the risk of hospital-acquired infections ... a UV disinfection robot that uses UVC light energy to kill deadly pathogens such as ... ... Tru-D in ...
Breaking Medicine Technology: